DXCM - DexCom Inc. (DXCM) Q4 2023 Earnings Call Transcript
2024-02-08 21:00:26 ET
DexCom, Inc. (DXCM)
Q4 2023 Earnings Conference Call
February 8, 2024 4:30 PM ET
Company Participants
Sean Christensen - Head of Investor Relations
Kevin Sayer - Chairman, President, and Chief Executive Officer
Jereme Sylvain - Chief Financial Officer
Conference Call Participants
Robbie Marcus - JPMorgan Chase and Company
Danielle Antalffy - UBS
Larry Biegelsen - Wells Fargo Securities
Mathew Blackman - Stifel Financial Corp.
Marie Thibault - BTIG
Jeff Johnson - Robert W. Baird and Company
Matt Taylor - Jefferies
Travis Steed - Bank of America Merrill Lynch
Joanne Wuensch - Citi
Matthew O'Brien - Piper Sandler
Malgaret Andrew - William Blair and Company
Jayson Bedford - Raymond James
Bill Plovanic - Canaccord Genuity
Michael Polark - Wolfe Research
Chris Pasquale - Nephron
Josh Jennings - TD Cowen
Mike Kratky - Leerink Partners
Steve Lichtman - Oppenheimer and Company
Matt Miksic - Barclays
Presentation
Operator
Ladies and gentlemen, welcome to the Dexcom Fourth Quarter and Fiscal Year 2023 Earnings Conference Call. My name is Abby and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and a-answer session.
[Operator instructions] As a reminder, the conference is being recorded. I will now turn the call over to Sean Christensen, Vice President of Finance and Investor Relations. You may begin.
Sean Christensen
Thank you, Aby, and welcome to Dexcom's fourth quarter and fiscal year 2023 earnings call. Our agenda begins with Kevin Sayer, Dexcom's Chairman, President, and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer. Following our prepared remarks, we will open the call up for your questions. At that time, we ask analysts to limit themselves to one question so we can provide an opportunity for everyone participating today.
Please note that there are also slides available related to our fourth quarter and fiscal year 2023 performance on the Dexcom investor relations website on the Events and Presentations page. With that, let's review our safe harbor statement. Some of the statements we will make in today's call may constitute forward-looking statements. These statements reflect management's intentions, beliefs, and expectations about future events, strategies, competition, products, operating plans, and performance....
DexCom, Inc. (DXCM) Q4 2023 Earnings Call Transcript